IL131917A0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
IL131917A0
IL131917A0 IL13191798A IL13191798A IL131917A0 IL 131917 A0 IL131917 A0 IL 131917A0 IL 13191798 A IL13191798 A IL 13191798A IL 13191798 A IL13191798 A IL 13191798A IL 131917 A0 IL131917 A0 IL 131917A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL13191798A
Other languages
English (en)
Other versions
IL131917A (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706295.4A external-priority patent/GB9706295D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to IL13809898A priority Critical patent/IL138098A/xx
Priority to IL13809800A priority patent/IL138098A0/xx
Publication of IL131917A publication Critical patent/IL131917A/xx
Publication of IL131917A0 publication Critical patent/IL131917A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL13191798A 1997-03-24 1998-03-20 Pharmaceutical compositions IL131917A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL13809898A IL138098A (en) 1997-03-24 1998-03-20 Use of lamivudine or pharmaceutically acceptable derivatives thereof for the manufacture of pharmaceutical compositions for use in the treatment or prophylaxis of viral infections
IL13809800A IL138098A0 (en) 1997-03-24 2000-08-25 Use of pharmaceutical compositions containing lamivudine for treating viral infections

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4235397P 1997-03-24 1997-03-24
GBGB9706295.4A GB9706295D0 (en) 1997-03-26 1997-03-26 Lamivudine formulation
PCT/EP1998/001626 WO1998042321A2 (en) 1997-03-24 1998-03-20 Liquid compositions comprising lamivudine

Publications (2)

Publication Number Publication Date
IL131917A IL131917A (en) 2001-01-11
IL131917A0 true IL131917A0 (en) 2001-03-19

Family

ID=26311267

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13191798A IL131917A0 (en) 1997-03-24 1998-03-20 Pharmaceutical compositions

Country Status (40)

Country Link
US (1) US6004968A (xx)
EP (1) EP0969815B1 (xx)
JP (1) JP3264937B2 (xx)
KR (1) KR100484695B1 (xx)
CN (1) CN1191061C (xx)
AP (1) AP1141A (xx)
AR (1) AR011697A1 (xx)
AT (1) ATE295150T1 (xx)
AU (1) AU728461B2 (xx)
BG (1) BG64690B1 (xx)
BR (1) BR9808060B1 (xx)
CA (1) CA2286126C (xx)
CO (1) CO4980849A1 (xx)
CY (1) CY2569B1 (xx)
CZ (1) CZ298008B6 (xx)
DE (1) DE69830154T2 (xx)
EA (1) EA001990B1 (xx)
EE (1) EE03996B1 (xx)
ES (1) ES2239802T3 (xx)
HK (1) HK1022853A1 (xx)
HN (1) HN1998000045A (xx)
HR (1) HRP980154B1 (xx)
HU (1) HU225600B1 (xx)
ID (1) ID29294A (xx)
IL (1) IL131917A0 (xx)
IS (1) IS2515B (xx)
MY (1) MY116242A (xx)
NO (1) NO326719B1 (xx)
NZ (1) NZ337798A (xx)
PA (1) PA8449301A1 (xx)
PE (1) PE61699A1 (xx)
PL (1) PL190505B1 (xx)
PT (1) PT969815E (xx)
RS (1) RS49772B (xx)
SI (1) SI0969815T1 (xx)
SK (1) SK283417B6 (xx)
SV (1) SV1998000040A (xx)
TW (1) TW536403B (xx)
UY (1) UY24930A1 (xx)
WO (1) WO1998042321A2 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4900074A1 (es) 1996-06-25 2000-03-27 Glaxo Group Ltd Combinaciones antivirales
US6018044A (en) * 1998-01-02 2000-01-25 Roche Vitamins Inc. Light screening compositions
US6432966B2 (en) * 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
JP2003039582A (ja) * 2001-07-19 2003-02-13 Three M Innovative Properties Co 湿潤防滑性シート及び湿潤防滑構造体
US6855346B2 (en) * 2001-10-05 2005-02-15 Tzu-Sheng Wu Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
MY131488A (en) * 2002-04-08 2007-08-30 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
KR101235507B1 (ko) * 2003-02-28 2013-02-20 추가이 세이야쿠 가부시키가이샤 단백질을 함유하는 안정화 제제
US20040228804A1 (en) * 2003-05-16 2004-11-18 Jones Alonzo H. Nasal administration of xylitol to a non-human mammal
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华(广州)医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
GB2470494B (en) * 2008-01-17 2012-08-08 Univ Holy Ghost Duquesne Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS
RU2587782C1 (ru) * 2015-01-19 2016-06-20 Общество с ограниченной ответственностью "Трейдсервис" Стабильная фармацевтическая композиция ламивудина

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
CZ285232B6 (cs) * 1991-05-16 1999-06-16 Glaxo Group Limited Protivirové směsi
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
GB9503850D0 (en) * 1995-02-25 1995-04-19 Glaxo Group Ltd Medicaments
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9605293D0 (en) * 1996-03-13 1996-05-15 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
PE61699A1 (es) 1999-07-08
EA199900757A1 (ru) 2000-08-28
CZ340399A3 (cs) 2000-04-12
JP2001501974A (ja) 2001-02-13
PL190505B1 (pl) 2005-12-30
KR20010005624A (ko) 2001-01-15
BR9808060B1 (pt) 2009-05-05
CO4980849A1 (es) 2000-11-27
AP1141A (en) 2003-01-29
PL336038A1 (en) 2000-06-05
CN1255849A (zh) 2000-06-07
AP9901657A0 (en) 1999-09-30
CZ298008B6 (cs) 2007-05-23
HRP980154B1 (en) 2002-06-30
NO994619D0 (no) 1999-09-23
HRP980154A2 (en) 1998-12-31
IS5184A (is) 1999-09-17
WO1998042321A3 (en) 1999-01-07
HUP0002982A3 (en) 2001-12-28
HN1998000045A (es) 1999-03-19
DE69830154T2 (de) 2005-10-13
RS49772B (sr) 2008-06-05
EA001990B1 (ru) 2001-10-22
SI0969815T1 (xx) 2005-08-31
AR011697A1 (es) 2000-08-30
HK1022853A1 (en) 2000-08-25
NO994619L (no) 1999-11-23
IL131917A (en) 2001-01-11
DE69830154D1 (de) 2005-06-16
ES2239802T3 (es) 2005-10-01
BG64690B1 (bg) 2005-12-30
YU47799A (sh) 2002-06-19
BG103818A (en) 2000-06-30
UY24930A1 (es) 2000-10-31
US6004968A (en) 1999-12-21
MY116242A (en) 2003-12-31
WO1998042321A2 (en) 1998-10-01
HU225600B1 (en) 2007-05-02
EP0969815A2 (en) 2000-01-12
SK129999A3 (en) 2000-07-11
PA8449301A1 (es) 2000-05-24
SV1998000040A (es) 1999-03-16
SK283417B6 (sk) 2003-07-01
CY2569B1 (en) 2008-07-02
NO326719B1 (no) 2009-02-02
IS2515B (is) 2009-06-15
EE03996B1 (et) 2003-04-15
ATE295150T1 (de) 2005-05-15
EP0969815B1 (en) 2005-05-11
HUP0002982A2 (hu) 2001-01-29
EE9900440A (et) 2000-04-17
BR9808060A (pt) 2000-03-08
CA2286126C (en) 2003-08-12
CA2286126A1 (en) 1998-10-01
TW536403B (en) 2003-06-11
PT969815E (pt) 2005-07-29
ID29294A (id) 2001-08-16
JP3264937B2 (ja) 2002-03-11
KR100484695B1 (ko) 2005-04-22
NZ337798A (en) 2001-03-30
AU728461B2 (en) 2001-01-11
AU7208498A (en) 1998-10-20
CN1191061C (zh) 2005-03-02

Similar Documents

Publication Publication Date Title
GB9727053D0 (en) Pharmaceutical compositions
EG24118A (en) Pharmaceutical compositions
GB9706089D0 (en) Pharmaceutical composition
CY2569B1 (en) Pharmaceutical compositions
GB9616672D0 (en) Pharmaceutical compositions
GB9610359D0 (en) Pharmaceutical compositions
GB9717444D0 (en) Pharmaceutical composition
IL131995A0 (en) Gastric-retained pharmaceutical compositions
GB9723985D0 (en) Pharmaceutical compositions
GB9717428D0 (en) Pharmaceutical composition
ZA9811532B (en) Pharmaceutical compositions
GB9622681D0 (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
GB9618376D0 (en) Pharmaceutical compositions
GB9717770D0 (en) Pharmaceutical composition
GB9610136D0 (en) Pharmaceutical compositions
GB9921495D0 (en) Pharmaceutical compositions
GB2321190B (en) Pharmaceutical composition
GB9726781D0 (en) Pharmaceutical composition
GB9718270D0 (en) Pharmaceutical compositions
GB9714328D0 (en) Pharmaceutical compositions
GB9710527D0 (en) Pharmaceutical compositions
GB9710505D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired